Non-interventional study for the generation of long term safety and efficacy data of pasireotide s.c. in patients with Cushing’s disease (Post-Authorization Safety Study)

Study identification

• EU PAS number:
  EUPAS3199
• Study ID:
  39654
• Official title and acronym:
  Non-interventional study for the generation of long term safety and efficacy data of pasireotide s.c. in patients with Cushing’s disease (Post-Authorization Safety Study)
• DARWIN EU® study:
  No
• Study countries:
  Canada

  Colombia

  France

  Germany

  Israel

  Italy

  Lebanon

  Netherlands

  United Kingdom

  United States
• Study description:
  No information provided.
• Study status:
  Finalised

Study timelines

Date when funding contract was signed

Actual:10/07/2012

Study start date

Planned:15/02/2013

Actual:28/03/2013

Date of final study report

Planned:26/09/2024

Actual:19/04/2024

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)